How should a nondisplaced Salter‑Harris type I fracture of the distal tibial growth plate in a child be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Nondisplaced Salter-Harris Type I Distal Tibia Fracture

A nondisplaced Salter-Harris type I fracture of the distal tibia should be treated with immobilization in a short leg cast or controlled ankle motion (CAM) boot for 3-4 weeks, followed by clinical reassessment without routine follow-up radiographs unless symptoms persist or new concerns arise. 1, 2

Initial Treatment Approach

  • Immobilize immediately with either a short leg cast or CAM boot for 3-4 weeks 1, 2
  • Provide short-course NSAIDs for analgesia 2
  • Ensure the immobilization device is not overtightened to avoid compromising circulation, particularly critical in young children 3

Key Clinical Rationale

  • Salter-Harris type I fractures involve only the growth plate (physis) without extension into the metaphysis or epiphysis, and have an excellent prognosis when nondisplaced 4
  • Pediatric patients possess exceptional bone remodeling potential, which allows for rapid healing with minimal risk of residual deformity in nondisplaced fractures 1
  • These fractures typically heal within 3-4 weeks in children due to their robust healing capacity 1, 2

Follow-Up Protocol

  • Do NOT obtain routine serial radiographs for stable, nondisplaced fractures healing appropriately 1
  • Clinical reassessment at 3-4 weeks to evaluate healing progress and ensure weight-bearing tolerance 3
  • Only obtain repeat imaging if:
    • New trauma occurs 1
    • Increased pain develops 1
    • Loss of range of motion is noted 1
    • Neurovascular symptoms appear 1
    • Initial radiographs were equivocal but clinical suspicion remains high (repeat at 10-14 days) 1, 2

Important Distinction from Displaced Fractures

  • This conservative approach applies only to nondisplaced fractures 5
  • Displaced Salter-Harris I fractures (≥3mm displacement) require closed reduction and carry a higher complication risk of 17% versus 2% for nondisplaced fractures 5
  • Salter-Harris type III and IV fractures of the distal tibia have much higher rates of growth disturbance and often require anatomic open reduction, but type I fractures when nondisplaced have minimal growth arrest risk 6, 7

Critical Pitfalls to Avoid

  • Avoid prolonged immobilization beyond 4 weeks, which leads to unnecessary stiffness, muscle atrophy, and delayed return to activities 1
  • Do not routinely obtain follow-up radiographs unless clinically indicated, as this increases healthcare contacts without changing management 1
  • Never assume normal initial radiographs rule out fracture in a symptomatic child—approximately 10% of tibial fractures are only visible on follow-up films at 7-14 days 2
  • Monitor for behavioral changes in young children (anxiety, agitation, increased analgesic requirements) as indicators of inadequate pain control or complications 1
  • Watch for signs of vascular compromise, which would require immediate intervention 3

Special Pediatric Considerations

  • At younger ages (toddlers through early adolescence), the growth plate is more vulnerable to injury but also heals more predictably when nondisplaced 1, 4
  • The distal tibial physis contributes significantly to lower extremity growth, but nondisplaced type I fractures rarely cause growth disturbance 6, 7
  • Educate families on maintaining immobilization despite the child's activity level and on recognizing signs of complications 3

References

Guideline

Management of Non-Displaced Great Toe Fracture in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Toddler's Fracture Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Non-Displaced Proximal First Metatarsal Fracture

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Growth plate injuries: Salter-Harris classification.

American family physician, 1992

Research

Distal tibial physeal fractures in children that may require open reduction.

The Journal of bone and joint surgery. American volume, 1984

Related Questions

What is the preferred diagnostic imaging method, spaced X-rays or Magnetic Resonance Imaging (MRI), to diagnose a potential fracture and displacement in a 14-year-old male with a suspected Salter-Harris type 1 fracture of the distal fibular physis, where the growth plate is not visible on initial X-ray?
Will spaced x-rays show anything that an MRI does not in a 14-year-old male with a suspected Salter-Harris type 1 fracture of the distal fibular physis, where the growth plate is not visible on initial x-ray, and there is concern for injury to the Anterior Talofibular Ligament (ATFL) and Calcaneofibular Ligament (CFL)?
What is the preferred diagnostic method, spaced x-rays or Magnetic Resonance Imaging (MRI), for a suspected Salter-Harris type 1 fracture of the distal fibular physis in a 14-year-old male with an invisible growth plate on initial x-ray?
What is the preferred diagnostic method, spaced x-rays or Magnetic Resonance Imaging (MRI), to confirm a suspected Salter-Harris type 1 fracture of the distal fibular physis in a 14-year-old male with an invisible growth plate on initial x-ray?
What is the benefit of Magnetic Resonance Imaging (MRI) versus serial X-rays to diagnose a suspected Salter-Harris type 1 fracture of the distal fibular physis in a 14-year-old male with an invisible growth plate on initial X-ray?
Is it safe to co‑prescribe naltrexone with aripiprazole, and what monitoring or dose adjustments are required?
Could a woman with low‑grade squamous intra‑epithelial lesion (LSIL) and negative high‑risk human papillomavirus (HPV) tests now and 14 months ago have adenocarcinoma in situ (AIS)?
What is the appropriate next therapeutic adjustment for an adult with type 2 diabetes on Humalog 75/25 (insulin lispro protamine suspension) 23 units twice daily, empagliflozin (Jardiance) 10 mg daily, and semaglutide (Ozempic) 2 mg weekly, whose continuous glucose monitor shows time‑in‑range 70‑180 mg/dL 75%, 181‑250 mg/dL 23% and glucose management indicator 7.1% (estimated average glucose 154 mg/dL)?
What are the side effects of naltrexone and what monitoring is recommended?
What is the likelihood that a woman with a low‑grade squamous intra‑epithelial lesion and two consecutive negative high‑risk human papillomavirus tests performed 14 months apart has any other form of invasive cervical cancer?
What is the appropriate treatment for a Bartholin's gland cyst?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.